Top Markets
Coin of the day
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

DPH
Classement en actions #24497
Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the... Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.
Prix de l'action
$52.60
Dernière synchronisation: 2024-01-15
Capitalisation boursière
$59.92M
Changement (1 jour)
6.81%
Changement (1 an)
0.00%
Pays
GB
Échange Dechra Pharmaceuticals PLC (DPH)

Catégorie

Le prix DPH avec la capitalisation boursière de B
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
DPH
$52.60
Capitalisation boursière de Dechra Pharmaceuticals PLC(DPH)
Capitalisation boursière: $59.92M
En August 2026, Dechra Pharmaceuticals PLC a une capitalisation boursière de $59.92M. Cela fait de Dechra Pharmaceuticals PLC la 24497th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Dechra Pharmaceuticals PLC du 2000 au 2026
DPH par rapport au top 5 des plus populaires stocks
Prix pour DPH L’actif B La capitalisation boursière de B Résultats
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$4,583,461 $59.92M
$5.221T +8,712,921.04%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,991,553 $59.92M
$4.547T +7,587,721.79%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,641,577 $59.92M
$4.148T +6,922,429.20%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$3,139,102 $59.92M
$3.576T +5,967,239.30%
Dechra Pharmaceuticals PLC Dechra Pharmaceuticals PLC
$2,440,099 $59.92M
$2.779T +4,638,455.59%